BioCryst Pharmaceuticals Inc. | Key People and Executives
Robert Alexander Ingram
Chairman
Jon P. Stonehouse
President, Chief Executive Officer & Director
George B. Abercrombie
Independent Director
Fred E. Cohen
Independent Director
Nancy J. Hutson
Independent Director
Ken B. Lee
Independent Director
Stanley C. Erck
Independent Director
Robert Alexander Ingram
Chairman
Jon P. Stonehouse
President, Chief Executive Officer & Director
Robert Bennett
Vice President-Investor Relations & Operations
Thomas R. Staab
CFO, Treasurer, Principal Accounting Officer & SVP
William P. Sheridan
Chief Medical Officer & Senior Vice President
Lynne M. Powell
Chief Commercial Officer & Senior Vice President
Yarlagadda S. Babu
Senior Vice President-Drug Discovery
Robert C. Stoner
Vice President-Human Resources
Alane P. Barnes
Secretary, Vice President & General Counsel
Elliott T. Berger
Senior Vice President-Regulatory Affairs
George B. Abercrombie
Independent Director
Fred E. Cohen
Independent Director
Nancy J. Hutson
Independent Director
Kenneth B. Lee
Independent Director
Stanley C. Erck
Independent Director
| Address |
4505 Emperor Boulevard
Durham North Carolina 27703
United States
|
|
Employees
|
- |
| Website |
http://www.biocryst.com |
| Updated |
07/08/2019 |
| BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. The firm focusses on oral treatments for rare diseases. Its portfolio includes Rapivab, Kallikrein inhibitors, and BCX4430. |
